As reassuring as stock market’s recovery has been from its February selloff, not everyone is sleeping comfortably.
Marginal improvements can be expected in the IT sector in the next fiscal, say brokerages after Nasscom’s guidance.
An otherwise strong earnings season for India’s companies is proving just not good enough for some.
What to invest in amid India’s changing micro story? CLSA suggests its top stock picks and sectoral bets.
This week’s auctions was a reminder that U.S. won’t have issues finding buyers for its debt as long as it pays up.
Ambuja Cements, Aurobindo Pharma, and Bosch will be excluded from the Nifty 50 Index.
Steps would be taken to ensure that ending licensing pacts do not disrupt the markets, said Indian exchanges.
It’s a setback for Sun Pharma’s U.S. operations.
Nearly 1.54 crore pledged shares of the company has been invoked on Feb. 17.
Rupee weakened due to higher global bond yields and local factors like the trade deficit and the PNB fraud.
Rising inflation expectations and the knock-on effect of higher yields are acting to prevent bonds from rallying.
Never fear, buy the dip is still here.
Morgan Stanley strategists say the recent stock slide was just an “appetizer, not the main course.”
It’s a lot for bond traders to chew on, after a bond-market rout pushed yields to multiyear highs last week.
Religare Enterprises’ revamped board is geared up to “go after” any borrowers that owe the company money.
An investor should plan the savings because any investment without a goal is purposeless, says Swarup Mohanty.
Bulls wondering if a rally would ever hold again got an answer Friday.
Och-Ziff Renegotiates Pay for Star Trader Levin for Co-CIO Role
KKR's Kravis, Roberts Pocket Combined $343 Million in 2017
Anbang Seizure Whets Buyers' Appetites for Buildings Across U.S.
Zhejiang Geely Holding will acquire a stake worth almost $9.2 billion in Daimler.
Monopolies Don't Explain Why Stocks Do Better Than the Economy
India is planning to ask PNB to compensate other banks for losses arising out of the $1.8 billion fraud.
Xi’s takeover of Anbang Insurance is confirmation about China’s determination to rein in surging corporate debt.
Central bankers are focusing on tightening monetary policy rather than pacifying nervous financial markets.